Eli Lilly Breaks Barriers: First Pharma Company Valued at $1 . . . Key Takeaways Eli Lilly has become the first pharmaceutical company to achieve a $1 trillion market valuation due to its successful obesity drugs The sales of Zepbound and Mounjaro have positioned Eli Lilly as a leader in the obesity treatment market, projected to reach $100 billion by 2030 Significant political discussions surrounding healthcare costs have emerged as Eli Lilly and
Eli Lilly becomes first drugmaker to hit $1 trillion in . . . Eli Lilly, the pharmaceutical company founded nearly 150 years ago by a Civil War veteran of the same name, on Friday briefly became the first drugmaker to reach $1 trillion in market value The milestone is the result of a vertiginous rise in Lilly’s stock price that stems from its success developing drugs for obesity